1. 281. Cefdinir Prescribing Increased in Low-Income Children in Kentucky From 2012 to 2016
- Author
-
Liza Creel, Navjyot Vidwan, Charles R. Woods, Bethany A. Wattles, Soutik Ghosal, John Myers, Michael J. Smith, and Yana Feygin
- Subjects
Low income ,Upper respiratory infections ,business.industry ,Virus diseases ,Cefdinir ,Abstracts ,Infectious Diseases ,Pharmacy (field) ,Oncology ,B. Poster Abstracts ,Environmental health ,medicine ,Antimicrobial stewardship ,business ,Medicaid ,medicine.drug - Abstract
Background Cefdinir is frequently prescribed to pediatric outpatients with respiratory infections despite a lack of first-line indications. The use of cefdinir should be limited given its poor efficacy against Streptococcus pneumoniae, suboptimal pharmacokinetic and pharmacodynamic parameters, and high cost. We describe cefdinir use over time in the pediatric Kentucky (KY) Medicaid population including rates of use, associated diagnoses, and cost to the Medicaid system. Methods We reviewed KY Medicaid pharmacy and medical claims from 2012 to 2016 for all patients
- Published
- 2018